卵圆孔未闭合并隐源性卒中的研究进展  

Advances in research of patent foramen ovale and cryptogenic stroke

作　　者：钟玉馨 王娟[3] 张长东 尚小珂[2] 夏远鹏[1] 曹非[1] ZHONG Yu-xin;WANG Juan;ZHANG Chang-dong;SHANG Xiao-ke;XIA Yuan-peng;CAO Fei(Department of Neurology Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Cardiovascular Surgery,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Center for Reproductive Medicine,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China)

机构地区：[1]华中科技大学同济医学院附属协和医院神经内科,湖北省武汉市430022 [2]华中科技大学同济医学院附属协和医院心脏大血管外科,湖北省武汉市430022 [3]华中科技大学同济医学院生殖专科医院

出　　处：《中国心血管病研究》2021年第1期90-94,共5页Chinese Journal of Cardiovascular Research

摘　　要：近年来越来越多的研究显示卵圆孔未闭(patent foramen ovale,PFO)与隐源性卒中(cryptogenic stroke,CS)的关系密切,与PFO相关的CS的治疗方案也一直是临床研究热点,对患者进行个体化评估选取最佳治疗方案至关重要。本文从国内外相关研究进展及对PFO封堵患者的评估与选择等方面做出论述,拟对临床上合并PFO的CS患者的治疗做出贡献。In recent years,studies have confirmed that cryptogenic strokes(CS)are closely related to patent foramen ovale(PFO)and clinical research is also increasingly focusing on the treatment of CS related to PFO.It is essential to evaluated the patients individually and choose the best treatment for the patients.In this review,the relevant research progress at home and abroad and the evaluation and selection of patients who ready for closure of PFO are discussed to make contributions to the clinical treatment of CS patients with PFO.

关 键 词：卵圆孔未闭 隐源性卒中 抗血小板治疗 抗凝治疗 封堵治疗 

分 类 号：R654.2[医药卫生—外科学]